BioSpace News Archive

Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, today announced that it will host a key opinion leader (KOL) webinar on the therapeutic potential of sotigalimab in post-anti-PD-(L)1 melanoma, the Company’s lead immuno-oncology candidate, on Friday, November 19, 2021 at 11:00 a.m. ET.

Concert Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Company Update

Aleta Biotherapeutics Announces ALETA-001 Presentation at 63rd ASH Annual Meeting

Novanta Announces Financial Results for the Third Quarter 2021

MYND LIFE SCIENCES INC. is pleased to announce its wholly-owned subsidiary MYND DIAGNOSTICS INC. has executed a binding letter of intent (“LOI”) with REVITALIST LIFESTYLE AND WELLNESS LTD.

SINOVAC Biotech Ltd. announced new preliminary data on its inactivated COVID-19 vaccine CoronaVac®.

ADC Therapeutics SA announced today that Chris Martin, PhD, Chief Executive Officer, will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, November 16th at 11:20 a.m. GMT / 6:20 a.m. EST.

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the B. Riley Securities’ Fall 2021 Growth Biotech Best Ideas Virtual Series, taking place on Thursday November 11, 2021, at 12:00 PM ET.

Statera Biopharma, Inc. announced today that the Company will host a conference call and live audio webcast on Monday, November 15, 2021, at 5:30 p.m. ET, to discuss its corporate and financial results for the third quarter of 2021.

Acerus Pharmaceuticals Corporation reported its financial results for the three and nine-month period ended September 30, 2021.